ParameswaranVenugopalMD

PubMed

• 27 citations
  Evaluation of the impact of cachexia on clinical outcomes in aggressive lymphoma.
  Madelyn Burkart, Michael Schieber, Sanjib Basu, Palmi Shah, Parameswaran Venugopal
  British Journal of Haematology. 2019-04-02
• 64 citations
  Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-...
  Azra Raza, Silvia Buonamici, Laurie Lisak, Sarah Tahir, Donglan Li
  Leukemia Research. 2004-08-01
• 242 citations
  Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.
  Azra Raza, Peter M. Meyer, Diya Dutt, Francesca Zorat, Laurie Lisak
  Blood. 2001-08-15

Journal Articles

• The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to Action  
  Agne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect
• Impact of Insulin-Like Growth Factor-1 & Insulin-Like Growth Factor Binding Protiens On Outcomes in Acute Myeloid Leukemia  
  Karmali, Reem; Larson, Melissa L; Shammo, Jamile; Basu, Sanjib; Christopherson, Kent W; Borgia, Jeffery A; Venugopal, Parameswaran, Leukemia & Lymphoma, 1/1/2015
• A phase III open label randomized study of cytarabine in comibination with amonafide L-malate or daunorubicin as inducation therapy for patients with secondary acute ...  
  Richard Stone, Emmanuele Mazola, Steven L Allen, Arnaud Pigneux, Robert K. Stuart, Meir Wetzler, David Rizzieri, Harry Paul Erba, Lloyd Damon, Junho Jang, Martin S. Ta..., Journal of Clinical Oncology, 1/1/2015
• All in The Family: Clueing Into The Link Between Metabolic Syndrome and Hematologic Malignancies  
  Reem Karmali, Hari Parameswaran, Hillard Lazarus and Parameswaran Venugopal, Blood Reviews, 1/1/2015
• Phase II study of 2-weekly CHOP+Rituximab followed by Yttrium 90 Ibritumomab Tiuxetan (Zevalin) in patients with previously untreated diffuse large B-cell lymphoma (DL...  
  Karmali R, Larson ML, Gregory SA, O’Brien T, Shammo JM, Venugopal P, Leukemia, 1/1/2014
• Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients  
  Karmali R, Paganessi LA, Frank RR, Jagan S, Larson ML, Venugopal P, Gregory SA, Christopherson KW 2nd, J Leukoc Biol., 1/1/2013
• A Phase III Open Label Randomized Study of Amonafide L- Malate in Combination with Cytarabine Compared with Daunofubicin in Combination with Cytarabine as Inducation T...  
  Stone, Richard; Mazzola, Emanuele; Neuberg, Donna; Allen Steven; Pigneux Arnaud; Stuart Robert; Wetzler, Meir; Rizzieri, David; Erba, Harry; Damon, Lloyd; Jang, Jun-Ho..., BLOOD, 1/1/2013
• Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients  
  Reem Karmali, Laura A. Paganessi, Robin R. Frank, Sucheta Jagan, Melissa L. Larson, Parameswaran Venugopal, Stephanie A. Gregory, and Kent W. Christopherson, II, J. Leukoc. Biol, 1/7/2012
• Erdheim Chester Disease  
  Eric M. Liotta, Miral D. Jhaveri, John C. Fox, Parameswaran Venugopal, Steven L. Lewis, Archives in Neurology, 1/1/2012
• Results of a Randomized Phase II Study of Oral Sapacitabine in Elderly Patients with Previously Untreated or First Relapsed Acute Myelokd Leukemia  
  Hagop Kantarjian, Stefan Faderl, Guillermo Garcia-Manero, Selina Luger, Parameswaran Venugopal, Lori Maness, Meir Wetzler, Steven Coutre, Wendy Stock, David Claxton, S..., Lancet Oncology, 1/1/2012
• GM-CSF-induced immune priming of CHOP-Rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma  
  Karmali R, Larson ML, Gregory SA, Wooldridge JE, O’Brien T, Shammo, JM, Bueschel K, Venugopal, P, Leukemia and Lymphoma, 1/1/2011
• Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front ...  
  Karmali R, Kassar M, Bayer R, Fung HC, O’Brien T, Shammo JM, Bueschel K, Venugopal P, Gregory SA, Clinical Lymphoma, Myeloma and Leukemia, 1/1/2011
• Clofarabine: a new treatment option for patients with acute myeloid leukemia  
  Larson ML, Venugopal, P, Expert Opin Pharmacother, 1/1/2009
• GM-CSF plus Rituximab immunotherapy: translation of biologic mechanisms into therapy for indolent B-cell lymphomas  
  SJ Schuster, P Venugopal, JC Kern, and P McLaughlin, Leukemia and Lymphoma, 1/1/2008
• Idiopathic Hemophagocytic syndrome with a fulminant clinical course  
  Abha Khandelwal, Neel B. Shah, Peter Eichenseer, Mile Welker, Ira Miller, Julie Nangia, Mohamed Farhat, Alla Gimelfarb, Mohammad Kasar, Marta Batus, Sefer Gezer, Jamil..., Clinical Advances in Hematology and Oncology, 1/1/2008
• Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation  
  Farhat M and Venugopal P, Clinical Advances in Hematology and Oncology, 1/1/2007
• Efficacy and safety of Rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive Non-Hodgkin’s lymphoma  
  Harting R, Venugopal P, Gregory SA and Obrien, T, Clin Lymphoma, 1/1/2007
• Post transplant Lymphoproliferative disorder: Extranodal Marginal Zone Lymphoma occurring after Renal Transplantation  
  Goldfarb J, Larson ML , Venugopal P and Gregory SA, Clin. Advances in Hematology and Oncology, 1/1/2006
• Recurrent Thrombotic Thrombocytopenic Purpura (TTP) Treated Repeatedly and Successfully with Monoclonal Antibody Rituximab  
  Herbei L, Venugopal P, Clinical Advances in Hematology and Oncology, 1/1/2006
• Integrating Rituximab Therapy with Transplantation in Relapsed/Refractory Lymphoma  
  Harting R and Venugopal P, Clinical Advances in Hematolgic Maligancies, 1/1/2006
• Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab  
  Go A, Venugopal P, Loew J, Djordjevic D, Clinical Advances in Hematology and Oncology, 1/1/2006
• Relapsed Non-Hodgkin’s Lymphoma in Fraternal Twins managed Successfully With Rituximab Maintenance Therapy  
  Chakravarti A, Leslie WT, Venugopal P, Clinical Advances in Hematology and Oncology, 1/1/2005
• Novel approaches to chemoimmunotherapy in Non-Hodgkin’s lymphoma: An update from ASCO 2005  
  Harting R, Venugopal P, Cancer Abstracts & Summaries, 1/1/2005
• The Combination of Fludarabine, Cyclophosphamide and Granulocyte-Macrophage Colony- Stimulating Factor in the Treatment of Patients with Relapsed Chronic Lymphocytic ...  
  Rao R, Shammo JM, Enschede SH, Porter C, Adler SS, Venugopal P, Gregory SA, Clinical Lymphoma, 1/1/2005
•  
  Enschede, S.E., Porter, C., Venugopal, P. and Gregory, S.A., Clinical Advances in Hematology and Oncology, 1/1/2004
• Join now to see all

Books/Book Chapters

• Management of Hematologic Malignancies 
  Chapter: Treatment Approaches to MALT/Marginal Zone Lymphomas 
  Stephanie A. Gregory and Parameswaran VenugopalEditors: Susan O'Brien, Julie M. Vose and Hagop M. Kantarjian.Cambridge Books2011
• ASHTM-SAP. American Society of Hematology Self Assessment Program 
  Chapter: Lymphoproliferative Disorders 
  Page 265 - 297Venugopal, P and Gregory, S.AEditors: S.A. Gregory and M.J. Kahn.American Society of Hematology, Washington, DCEdition 3rd,2007
• Cancer, Principles and practice of oncology review 
  Page 376 - 390William T. Leslie and Parameswaran Venugopal. Hodkin Disease and Non-Hodgkin Lymphomas in Devita, Hellman, and Rosenberg’sEditors: Ramaswamy Govindan.Lippincott Williams and WilkinsEdition 1st,2005
• Autologous Blood and Bone Marrow Transplantation, Proceedings of the Tenth International Symposium 
  Chapter: A View of Myelodysplastic Syndrome as an Infectious Disease 
  Page 302 - 311Azra Raza, Francesca Zorat, Fabiana Nascimben, Suneel Mundle, Vilasini Shetty, Poluru Reddy, Krishnan Allampallam, Sairah Alvi, Ahmad Shaher, Mona Tareen, Parameswaran...Editors: Karel A. Dickie & Armand Keating.Cardens Jennings Publishing, Charlottesville, VA2000
• Acute Leukemia VII, Experimental Approaches and Novel therapies 
  Chapter: Control of leukemia proliferation in vivo in patients: In vivo cytokine production 
  Preisler HD, Gao XZ, Chopra H, Devemy E, Venugopal P, Bi SEditors: Hiddemann W, Buchner T, Wormann B, Ritter J, Creutzig U, Keating M, Plunkett W.Springer-Verlag Berlin Heidelberg1998
• Pilot Study of Pentoxifylline and Ciprofloxacin with or without dexamethasone produces encouraging results in myelodysplastic syndromes 
  Chapter: Pilot Study of Pentoxifylline and Ciprofloxacin with or without dexamethasone produces encouraging results in myelodysplastic syndromes 
  Page 42 - 51A. Raza, P. Venugopal, S. Gezer, S.A. Gregory, L.-M. Dong, S. Leurgens, S.D. Mundle, V. T. Shetty, S. Alvi, A. Ali, L. Span, S.E. Dar, C. Hines, W.T. Hsu, J. Loew, R.Z...Editors: Hiddemann W, Buchner T, Wormann B, Ritter J, Creutzig U, Keating M, Plunkett W.Springer-Verlag Berlin Heidelberg1998
• Drug Resistance in Leukemia and Lymphoma - The Clinical Value of Laboratory Studies 
  Chapter: Predictive Assays in Acute Leukemia 
  Page 17 - 32Preisler HD, Raza A, Gopal VEditors: Kaspers GJL, Pieters R, Twentyman PR, Weisenthal LM, Veerman AJP.Harwood Academic Publishers1992
• The Status of Differentiation Therapy of Cancer 
  Chapter: The Use of Biologically Active Agents in the Treatment of AML and other Neoplastic Diseases 
  Page 379 - 386Preisler HD, Raza A, Hulette B, Silvestri F, Li YQ, Shripad B and Venu Gopal PEditors: Waxman S, Rossi GB, Takaku F.Serona Symposia, Raven Press1991
• Join now to see all

Abstracts/Posters

• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Parameswaran Venugopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Parameswaran Venugopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Marked lymphocytosis in Hairy Cell Leukemia: Need for caution when diagnosing Variant Hairy Cell Leukemia
  Sahr Syed, Jason Macklis, Parameswaran Venugopal, Brett Mahon, CAP’15 meeting, Nashville, TN, 1/7/2015
• Characterization of the clinical and biological features of primary bone lymphomas
  Kam A, Venugopal P, Karmali R, Pan-Pacific Lymphoma Conference, 1/1/2014
• Efficacy of dose-dense CHOP-R-14 followed by Yttrium 90 Ibritumomab in high risk untreated diffuse large B-cell lymphoma (DLBCL)
  Karmali R, Gregory SA, Shammo JM, Larson ML, Venugopal P, Pan-Pacific Lymphoma Conference, 1/1/2014
• Link between metabolic syndrome and survival outcomes in mantle cell lymphoma
  Kim SH, Venugopal P, Karmali R, Pan-Pacific Lymphoma Conference, 1/1/2014
• Impact of circulating members of the insulin-like growth factor receptor (IGF-1R) axis on outcomes in acute myeloid leukemia
  Impact of circulating members of the insulin-like growth factor receptor (IGF-1R) axis on outcomes in acute myeloid leukemia, J Clin Oncol, 1/1/2014
• Influence of BMI on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML
  Mansoor Burhani, Manish J. Dave, Parameswaran Venugopal, and Melissa L. Larson, ASCO Meeting, 1/1/2013
• The effect of BMI on systemic toxicity in AML patients receiving chemotherapy
  Manish J. Dave, Mansoor Burhani, Parameswaran Venugopal, and Melissa L. Larson, ASCO Meeting, 1/1/2013
• Certification and role of local pathologists for diffuse large B-cell lymphoma (DLBCL) subtyping and eligibility determination in the phase II PYRAMID study
  Jonathan W. Said, James Andrew Reeves, Ian Flinn, Anil Tulpule, Robert Leon Robles, Christopher Flowers, Nicholas J. DiBella, Kathryn S. Kolibaba, Parameswaran Venugop..., ASCO Meeting, 1/1/2013
• Incidence and characteristics of Therapy-Related Myeloid Neoplasms in Patients with Non-Hodgkins Lymphoma Treated with Radioimmunotherapy
  Salman Waheed, Iva Ferreira, Deborah A Katz, Reem Karmali, Stephanie A Gregory, Parameswaran Venugopal, Jamile M Shammo, Americal Society of Hematology Annual Meeting, 1/1/2012
• Effect of Radioimmunotherapy on Stem Cell Mobilization: A single institution experience
  Anna W Chalmers, Reem Karmali, Parameswaran Venugopal, Stephanie A Gregory, Sunita Nathan, Henry Fung, American Society of Hematology Annual Meeting, 1/1/2012
• Pooled analysis of elderly patients with newly diagnosed AML treated with sapacitabine and decitabine administered in alternating cycles
  Farhad Ravandi1, Mahendra Kadia, Gautam Borthakur, William G. Wierda, Stuart Goldberg, Meir Wetzler, Parameswaran Venugopal, Karen Seiter, Judy H. Chiao and Hagop ..., Americal Society of Hematology Annual Meeting, 1/1/2012
• Engraftment Kinetics After Alemtuzumab-Based Allogeneic Stem Cell ransplant (SCT): Full Donor T-Cell Chimerism Did Not Predict for Acute Graft Versus Host Disease (GVH...
  Henry C Fung, Muhammed Alikhan, Lela Buckingham, John J Maciejewski, Reem Karmali, Kent W Christopherson II, Elizabeth Shima Rich, Parameswaran Venugopal, Stephanie A ..., American Society of Hematology Annual Meeting, 1/1/2012
• Efficacy of a non-anthracycline regimen using cytarabine and etoposide as second line therapy for relapsed/refractory acute myeloid leukemia
  Gatha Nair, Reem Karmali, Parameswaran Venugopal, Melissa Larson, American Society of Clinical Oncology, Chicago, IL, 1/1/2011
• Comparison of Ara-C, Mitoxantrone and CNDAC In Vitro Treatment of AML Bone Marrow and Peripheral Blood Cells
  Sucheta Jagan, Laura A. Paganessi, Dana Rifai, Margaret C. Keller, Melissa L. Larson, Parameswaran Venugopal, Sheelagh Frame, Simon Green and Kent W. Christopherson II, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2011
• Hemoglobin H Diseas
  Sefer Gezer, Parameswaran Venugopal and Melissa L. Larson, Rush University Research Forum, 1/1/2011
• FLT3 positive acute myeloid leukemia: Does times sequential induction therapy influence outcome?
  D. Rifai, M.L. Larson, M.C. Keller, P. Venugopal, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2011
• A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (AC...
  R. M. Stone, S. L. Allen, A. Pigneux, R. K. Stuart, M. Wetzler, D. Rizzieri, H. P. Erba, L. E. Damon, J. H. Jang, M. S. Tallman, K. Warzocha, T. Masszi, M. A. Sekeres,..., Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2011
• High ferritin levels before allogeneic hematopoietic cell transplantation (AlloHCT) are associated with adverse transplant outcomes- a retrospective study to evaluate ...
  S. Hashmi, E. S. Rich, S. Basu, J. J. Maciejewski, S. Nathan, P. Venugopal, S. A. Gregory, H. C. Fung, J. M. Shammo; West Suburban Medical Center, Oak Park, IL; Rush U..., Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2011
• VSLI (vincristine sulfate liposomes injection) “Bridging” to Potentially Curative Hemopoietic Stem Cell Transplantation (HSCT) in Adults with Phhiladelphia Chromosome ...
  Gary Schiller, Steven Coutre, Melissa Larson, Dina Ben Yehuda, Parameswaran Venugopal, Stuart Goldberg, Gerald Messerschmidt, Jeffrey Silverman, Steven R. Deitcher, Ha..., Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2011
• Phase 1/ 2 Study of Sapacitabine and Decitabine Administered Sequentially in Elderly Patients with Newly Diagnosed AML
  Farhad Ravandi, MD, Stefan Faderl, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero1, Elias Jabbour, MD, Patricia Ann Boone, Tapan Kadia1, Gautam Borthakur, William G...., 53rd Annual Meeting of the American Society of Hematology, San Diego, CA, 1/1/2011
• Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum
  Laura A Paganessi, MA, Robin R Frank, Sucheta Jagan, Reem Karmali, MD, Yan Li, Youping Deng*, Cristina L Fhied, Jeffrey A Borgia, PhD, Melissa L Larson, M.D, Parameswa..., 53rd Annual Meeting of the American Society of Hematology, San Diego, CA, 1/1/2011
• A Long-Term Follow-up Report on Autologous Hematopoetic Cell Transplant (AuHCT) for Patients with Hodgkin Lymphoma - Limited Utility of Post-Transplant Surveillance Co...
  Henry C. Fung, FRCP, MD, Sunita Nathan, MD, Neel B. Shah, MD, John J. Maciejewski, MD, PhD, Elizabeth Shima Rich, MD, PhD, Jennifer Tornatta, MS, ANP, Nancy Licciardi,..., 53rd Annual Meeting of the American Society of Hematology, San Diego, CA, 1/1/2011
• CD20, CD22, CD23, but Not CD37 Expression on CD19+ B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukem...
  Robin R Frank, BS, Sucheta Jagan, MS, Laura A Paganessi, MA, Melissa L Larson, M.D, Reem Karmali, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD and Kent W C..., 53rd Annual Meeting of the American Society of Hematology, San Diego, CA, 1/1/2011
• Join now to see all

Lectures

• Copanlisib for Follicular Lymphoma. FDA Approvals and Their Incorporation into Clinical Practice 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Management of High Risk Aggressive Lymphoma 
  Coeur d'alene, ID - 1/28/2015
• Hodgkin Lymphoma, management 
  1/26/2015
• Advances in the Management of Aggressive Lymphomas 
  ID - 1/15/2014
• Advances in the Management of Chronic Lymphocytic Leukemia 
  ID - 1/15/2014
• Chronic Lymphatic Leukemia: a model for drug development in Hematology & Oncology 
  Trivandrum, India - 1/8/2014
• Update on management of CLL 
  1/30/2013
• Advances in Hematologic Malignancies 
  Wheeling, IL - 1/22/2013
• Update on Management of Non-Hodgkin’s Lymphoma 
  1/30/2008
• Treatment Breakout Sessions: Antibody therapy 
  1/28/2008
• Current Trends in the Treatment of Non-Hodgkin’s Lymphoma and Multiple Myeloma 
  Munster, IN - 1/15/2008
• Advances in the Management of Multiple Myeloma 
  Willobrook, IL - 1/15/2008
• Advances in the management of Myelodysplastic Syndromes 
  1/7/2008
• Multiple Myeloma: Translating the Evidence Into Clinical Practice 
  DeKalh, IL - 1/1/2008
• Emerging Trends in Oncology 
  Pasadena, CA - 1/30/2007
• Non-Hodgkin’s Lymphoma 
  Aurora, IL - 1/26/2007
• Acute Myeloid Leukemia and Myelodysplastic Syndromes 
  Waukegan, IL - 1/23/2007
• Multidisciplinary Approach to diagnosis: 45 Y.O. man with fevers, adrenal masses and shortness of breath 
  1/18/2007
• Optimizing Therapy for CD-20 Expressing B-Cell Malignancies 
  Munster, IN - 1/13/2007
• Current Trends in Leukemia, Lymphoma and Myeloma 
  Seattle, WA, 2007; Chicago, IL, 2007 - 1/13/2007
• Options for Follicular Lymphoma 
  Rosemont, IL - 1/12/2007
• Monoclonal Antibody Therapy in Lymphoma 
  Kankakee, IL - 1/10/2007
• Leukemia, Lymphoma and Myelodysplastic Syndromes: for patients, families and friends 
  Westin Hotel, Rosemont, IL - 1/30/2005
• Lymphoma 
  Multiple Locations, 2005, 2002 - 1/15/2005
• Emerging Trends in Oncology: A Post-ASCO Update 
  Dallas, TX - 1/11/2005
• Join now to see all